Delaware Patent of the Month – January 2022

In some treatment methods, reducing cell viability has great potential. Reducing the viability, inducing cell apoptosis (cell death), and inhibiting cell spread could, for instance, treat cancer by preventing it from spreading and inducing its own self-death. Cyclooxygenase (COX) is an enzyme linked to cancer pathogenesis. As such, there have been attempts at creating anti-cancer treatments targeting COX-2. However, these attempts are limited by the appearance of toxic side effects. These effects range from nephrotoxicity to cardiotoxicity.

GLAX, LLC, a biomedical R&D company, has developed a method of reducing cell viability without introducing these common toxic side effects. The company has developed a controlled-release treatment which combines anticancer effects with anti-inflammatory effects. This treatment uses Prostaglandin Endoperoxide Synthetase-2 (PTGS-2) inhibitors. PTGS-2 is a gene which encodes for COX-2. By inhibiting the gene, COX-2 is inhibited and therefore cancer pathogenesis is limited. With the combination of anticancer and anti-inflammatory help to limit toxic side effects while delivering reduced cell viability.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at or contact your usual Swanson Reed representative.

Recent Posts